CAMP Q3 2021 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M-5.4% YoY

Gross Profit

$33M42.2% margin

Operating Income

-$998,000-1.3% margin

Net Income

-$5M-6.9% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-0.8%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$419M

Total Liabilities

$329M

Stockholders' Equity

$90M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$84M	-5.4%
Gross Profit	$33M	$31M	+8.3%
Operating Income	-$998,000	-$6M	+84.0%
Net Income	-$5M	-$9M	+42.8%

Revenue Segments

Product

$52M65%

Application Subscriptions And Other Services

$27M35%

Geographic Segments

U S

$54M69%

E M E A

$13M16%

South America

$8M10%

Asia Pacific

$3M4%

All Other

$1M2%